Hetero launches antiviral Covid-19 drug favipiravir at Rs 59 per tablet



Drug firm Hetero on Wednesday said it has launched genericoral antiviral drug Favipiravir used forthe treatment of patients with mild to moderate Covid-19,in India under the brand name 'Favivir' at Rs 59 per tablet.

The company has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI), Hetero said in a statement.

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of Covid-19, it added.

Themedication has demonstrated positive clinical outcomes. It improves treatment accessibility to a significant amount of Covid-19 patient population, which have mild to moderate symptoms, Hetero said. Read More


Comments

Popular posts from this blog

Invest in smallcase with sebi registered professionals

Teji Mandi Your Ultimate Share Market App for Informed Investing

Unleashing the Potential of Stocks: Crafting a Successful Stock Portfolio